Since its inception, The Methodist Hospital Research Institute has challenged the traditional paradigm of medical research, building a new model for translational research that forgoes siloed programs in favor of collaborative platforms that form the interfaces between internal and external boundaries.
Led by Mauro Ferrari, Ph.D., President and CEO, the Research Institute is a 540,000-square-foot research enterprise that extends throughout The Methodist Hospital System in Houston, TX, and is affiliated with Weill Cornell Medical College (WCMC) in New York City. Methodist is fully equipped to support the development of interdisciplinary technology and move it through the translational cycle.
Our facilities include a cyclotron, pre-clinical and clinical imaging (PET/CT, SPECT/CT, MRI), flow cytometry and microscopy, small and large animal vivarium; and a GMP facility for nanoparticles, contrast agents, vaccines, and therapeutic molecules. These resources are vertically integrated with the research labs in a single building that is physically connected to our central campus in the heart of Texas Medical Center. Our translational researchers and physician scientists work closely to apply research to clinical applications- our 260 faculty members currently conduct research studies supported by $120 million in research expenditures and coordinate more than 800 clinical trials.
The Department of Translational Imaging is committed to the advancement of medical imaging technology including the development and clinical application of novel molecular imaging agents and other devices and technologies to diagnose disease, guide procedures, monitor therapeutic response, and treat disease with greater specificity and sensitivity. A multidisciplinary group of highly qualified scientists and researchers in molecular pathology, molecular biology, synthetic chemistry, radiochemistry, image processing, and imaging physics work together as a team to advance imaging technology, focusing on the translation of laboratory breakthroughs into clinical practice. The department has a joint program in molecular imaging with WCMC.
We are seeking a highly qualified individual to lead the Department of Translational Imaging. The candidate for the Department Chair should be an established clinical investigator (M.D. and Ph.D. preferred), with a strong history of leading clinical trials, academic accomplishments at a full professor level, track record of successful grant funding, proven leadership of a large research team, and an ability to organize and direct interdisciplinary and translational programs. The candidate should be a nuclear imaging expert with a personal primary focus in neurology, oncology or cardiology. The candidate is expected to have a strong interest in leading programmatic developments of medical application of nuclear medicine in the areas that are not her/his primary focus, and in further developing a programmatic thrust in magnetic resonance imaging. The candidate will also continue to lead the vibrant and collegial collaboration with the joint Molecular Imaging Program with WCMC.
Applicants should submit a Statement of Scientific Interest, Curriculum Vitae and the names of three references to:
Tong Sun, Director of Central Operations
The Methodist Hospital Research Institute
6670 Bertner St., M.S. R2-216
Houston, TX 77030
Candidates may also email firstname.lastname@example.org. Please specify the applying field in the subject line of your email.
Our success as an organization is due to the diversity of our team. We are an equal opportunity employer.